Jump to content
IndiaDivine.org

FDA needs its own warning label

Rate this topic


Guest guest

Recommended Posts

> SSRI-Research

> Thu, 16 Sep 2004 19:34:10 -0700 (PDT)

> [sSRI-Research] FDA needs its own warning

> label

>

> FDA needs its own warning label

>

> Published on: 09/12/04 || The Atlanta Journal

> Constitution

>

> The U.S. Food and Drug Administration's policy on

> warning labels for

> antidepressants that are prescribed for children and

> adolescents is more

> than bizarre; it's downright dangerous.

>

> During congressional hearings last week, agency

> officials admitted they had

> urged drug makers on several occasions not to inform

> doctors or their

> patients that products such as Paxil and Zoloft,

> while helpful for adults,

> weren't proved to be any more effective than inert

> sugar pills in treating

> childhood depression. Even more startling is that

> they made those

> recommendations despite knowledge that some of the

> drugs increased " suicidal

> thoughts " in young people.

>

> This is truly strange behavior for an agency that's

> supposed to be looking

> out for consumers who lack the expertise to protect

> themselves from unsafe

> drugs. In 2002, nearly 11 million antidepressant

> prescriptions were written

> for children, including 2.7 million for children

> under 12. Despite their

> popularity, more than two-thirds of all studies of

> antidepressant use among

> depressed children showed they didn't work.

>

> Drug trials and studies are typically conducted at

> public expense but often

> represent billion-dollar windfalls for drug makers

> by enabling them to

> extend the useful life of profitable patents. The

> hearings included

> testimony from all the heavy hitters of " Big

> Pharma " : Pfizer, Wyeth and

> GlaxoSmithKline.

>

> But the most troubling revelation was that the FDA

> advocated suppressing or

> diluting warnings about some antidepressants for

> kids, often over drug

> makers' repeated objections. Wyeth, for example,

> wanted to alert consumers

> that the antidepressant Effexor had been linked to

> suicidal thinking,

> hostility and self-harm. But the agency demurred,

> saying the company's

> suggested warning was " not understandable. "

>

> Earlier in the hearings, Rep. Joe L. Barton

> (R-Texas), who chairs the House

> Energy and Commerce Committee, accused top FDA

> officials of stonewalling.

>

> " The FDA's lack of cooperation with the committee in

> obtaining relevant and

> responsive information in a timely fashion on a

> matter that involves the

> safety of our children leaves me wondering whether

> this is sheer ineptitude

> or something far worse, " Barton said.

>

> An industry trade group has offered to voluntarily

> publicize the results of

> all clinical drug trials on the Internet, but that's

> not nearly enough. The

> only way to begin fixing the current system is for

> Congress to pass

> legislation making such disclosures mandatory. After

> that, a shakeout of FDA

> officials who have shamefully abdicated their

> responsibility to protect the

> public would be just the right medicine.

>

> =========================

>

> http://tinyurl.com/4sogc

>

> --

> Alex Chernavsky

> alexc

> http://www.astrocyte-design.com/

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...